360Dx

droplet digital PCR

May 04, 2020

Bio-Rad Laboratories Gets FDA Emergency Use Authorization for ddPCR COVID-19 Assay

The triplex assay can be used on the firm's QX200 or QXDx Droplet Digital PCR systems to process 93 patient samples per run.

Apr 16, 2020

Multi-Analyte Liquid Biopsy Panel May Aid in Pancreatic Cancer Detection, Staging

Premium

The panel's developers at UPenn hope to validate and commercialize a non-invasive assay through a startup called Chip Diagnostics.

Mar 29, 2020

Bio-Rad Laboratories ddPCR Shows Accuracy Benefits in COVID-19 Detection Studies

Droplet digital PCR tests for SARS-CoV-2 can potentially detect the very low viral loads seen in asymptomatic and convalescent cases.

Feb 10, 2020

Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study

Premium

The technology uses single-cell droplet digital PCR to analyze maternal blood cell populations that have been enriched for fetal cells by MACS.

Jan 13, 2020

JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics

On Monday Qiagen reiterated its preliminary 2019 earnings figures and addressed an investor's wrath, while Guardant Health highlighted its cancer testing plans.

Oct 31, 2019

Bio-Rad's Q3 Revenues Increase 3 Percent, Beat Analysts' Estimate

The firm saw modest growth across both of its business segments and double-digit growth in its droplet digital PCR product line.

Aug 01, 2019

Bio-Rad Q2 Revenues Down 1 Percent

The life science segment saw strong sales in Droplet Digital PCR offset by sales the firm's process media product line.

May 08, 2019

Bio-Rad Laboratories Reports Flat Q1 Revenues

Bio-Rad also disclosed during an earnings call that it acquired an undisclosed company that will expand its genomic reagents product portfolio.

Mar 05, 2019

Lung Cancer Diagnostic Approach Takes Aim at Identifying Malignancy, Guiding Immunotherapy From Single Sample

Premium

Researchers at RMIT University have described collecting bronchial brushings as part of a molecular approach that may enable diagnosing lung cancer patients and guiding therapies.

Feb 28, 2019

Bio-Rad Q4 Revenues Down 1 Percent, Beat Estimates

The company's full-year revenues rose 6 percent and were slightly higher than the consensus Wall Street estimate.

Pages